- Home
- RNAZ vs ATER Comparison
RNAZ vs ATER Comparison
Compare RNAZ & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- ATER
- Stock Information
- Founded
- RNAZ 2016
- ATER 2014
- Country
- RNAZ United States
- ATER United States
- Employees
- RNAZ N/A
- ATER N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- ATER Home Furnishings
- Sector
- RNAZ Health Care
- ATER Consumer Discretionary
- Exchange
- RNAZ Nasdaq
- ATER Nasdaq
- Market Cap
- RNAZ 8.7M
- ATER 10.3M
- IPO Year
- RNAZ 2021
- ATER N/A
- Fundamental
- Price
- RNAZ $13.77
- ATER $1.02
- Analyst Decision
- RNAZ Strong Buy
- ATER
- Analyst Count
- RNAZ 1
- ATER 0
- Target Price
- RNAZ $280.00
- ATER N/A
- AVG Volume (30 Days)
- RNAZ 421.5K
- ATER 111.0K
- Earning Date
- RNAZ 11-13-2025
- ATER 11-10-2025
- Dividend Yield
- RNAZ N/A
- ATER N/A
- EPS Growth
- RNAZ N/A
- ATER N/A
- EPS
- RNAZ N/A
- ATER N/A
- Revenue
- RNAZ N/A
- ATER $85,668,000.00
- Revenue This Year
- RNAZ N/A
- ATER N/A
- Revenue Next Year
- RNAZ N/A
- ATER $7.48
- P/E Ratio
- RNAZ N/A
- ATER N/A
- Revenue Growth
- RNAZ N/A
- ATER N/A
- 52 Week Low
- RNAZ $6.15
- ATER $0.90
- 52 Week High
- RNAZ $643.94
- ATER $3.50
- Technical
- Relative Strength Index (RSI)
- RNAZ 55.86
- ATER 45.80
- Support Level
- RNAZ $12.11
- ATER $0.95
- Resistance Level
- RNAZ $15.49
- ATER $1.12
- Average True Range (ATR)
- RNAZ 1.74
- ATER 0.07
- MACD
- RNAZ -0.13
- ATER -0.01
- Stochastic Oscillator
- RNAZ 23.76
- ATER 22.56
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.